Plerixafor (Mozobil)

From - A Hematology Oncology Wiki
Jump to: navigation, search

General information

Class/mechanism: Mobilizes hematopoetic stem cells by inhibiting the CXCR4 chemokine receptor and blocking its cognate ligand, stromal cell-derived factor-1α (SDF-1α). One function of CXCR4 is to anchor stem cells to the marrow matrix via SDF-1α or other adhesion molecules.[1][2]
Route: SC
Extravasation: n/a

For conciseness and simplicity, currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]

Patient drug information

Also known as

  • Code name: AMD3100
  • Brand name: Mozobil


  1. 1.0 1.1 Plerixafor (Mozobil) package insert
  2. Plerixafor (Mozobil) package insert (locally hosted backup)
  3. Plerixafor (Mozobil) patient drug information (UpToDate)